Indivior News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

31.03.22	Indivior to Commence Formal Shareholder Consultations on Additional US Listing (PR Newswire)
16.02.22	Indivior Announces Q4 and FY 2021 Results (PR Newswire)
27.01.22	Research Indicates Sustained High Plasma Concentrations of Buprenorphine Reduce Fentanyl-Induced Respiratory Depression in Opioid-Tolerant Participants (PR Newswire)
01.11.21	Indivior Presents Study at the 2021 National Commission on Correctional Healthcare Conference on Factors Impacting Medications for Opioid Use Disorder Treatment Approaches in Criminal Justice-Invo... (PR Newswire)
21.10.21	Indivior to Present New Data on Opioid Use Disorder at CSAM-SMCA 2021 Scientific Conference (PR Newswire)
29.06.21	Indivior Finance S.ar.l. -- Moody's assigns B2 ratings to Indivior's new term loan (Moodys)
24.06.21	Indivior Presents New Data at the College on Problems of Drug Dependence (CPDD) 2021 Annual Conference (PR Newswire)
08.06.21	Indivior Extends Leadership Position In Substance Use Disorder Treatment With Exclusive Agreement For Leading Asset Targeting Cannabis-Related Disorders (PR Newswire)
04.06.21	Indivior Finance S.ar.l. -- Moody's upgrades Indivior's CFR to B2; outlook stable (Moodys)
02.06.21	Indivior Finance S.ar.l. -- Moody's upgrades Indivior's CFR to B2; outlook stable (Moodys)
12.03.21	Reckitt Benckiser Treasury Services B.V. -- Moody's changes Reckitt Benckiser's outlook to stable from negative; affirms A3 rating (Moodys)
15.12.20	Indivior Finance S.ar.l. -- Moody's announces completion of a periodic review of ratings of RBP Global Holdings Ltd (Moodys)
24.07.20	Indivior Finance S.ar.l. -- Moody's affirms Indivior's B3 CFR; outlook revised to stable (Moodys)
14.05.20	Drugmaker Indivior profit slumps on higher legal, promotion costs (Reuters)
14.05.20	Indivior profit slumps on legal costs, higher litigation provisions (Reuters)
13.05.20	Reckitt Benckiser Group Plc -- Moody's assigns A3 ratings to Reckitt Benckiser's new unsecured notes; outlook negative (Moodys)
11.05.20	Reckitt Benckiser Treasury Services Plc -- Moody's assigns A3 ratings to Reckitt Benckiser's new unsecured notes; outlook negative (Moodys)
08.04.20	Indivior withdraws 2020 forecast on coronavirus-led uncertainty (Reuters)
03.03.20	Reckitt Benckiser Treasury Services Plc -- Moody's changes Reckitt Benckiser's outlook to negative from stable; affirms A3 rating (Moodys)
13.02.20	Indivior posts steep quarterly loss as copycat drugs bite, shares plunge (Reuters)
14.01.20	Indivior Finance S.ar.l. -- Moody's announces completion of a periodic review of ratings of RBP Global Holdings Ltd (Moodys)
13.07.19	Indivior loses appeal to block generic Suboxone opioid treatments (Reuters)
11.07.19	Reckitt to pay $1.4 billion to end long-running Indivior probes (Reuters)
11.07.19	Indivior lifts FY profit view on slower erosion of Suboxone market share (Reuters)
11.07.19	UK's Reckitt Benckiser to pay up to $1.4 billion to end Indivior probe (Reuters)
09.05.19	Indivior signs deal to sell schizophrenia drug in Canada (Reuters)
11.04.19	Indivior shares plummet, Reckitt hurt on U.S. charges over opioid prescriptions (Reuters)
10.04.19	Reckitt plays down Indivior risk to infant formula business (Reuters)
10.04.19	U.S. charges pummel drugmaker Indivior, hurt Reckitt (Reuters)
10.04.19	FTSE 100 little changed ahead of Brexit summit, Indivior tanks (Reuters)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’299.00	2.40 %	K V
Holcim	89.04	1.09 %	K V
Roche Hldg G	266.90	0.95 %	K V
ABB	49.88	0.81 %	K V
Novartis	90.96	0.63 %	K V
Givaudan	3’882.00	-0.54 %	K V
Zurich Insur Gr	547.20	-0.83 %	K V
Alcon	76.34	-1.14 %	K V
Logitech Intl	78.74	-1.43 %	K V
Geberit	505.80	-1.52 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Indivior PLC (spons. ADRs)

Aktien Top/Flop

Meistgelesene Nachrichten